Carl Zeiss Meditec AG (AFX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Carl Zeiss Meditec AG (AFX) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€144.16 Million ≈ $168.54 Million USD) by net assets (€2.13 Billion ≈ $2.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Carl Zeiss Meditec AG - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Carl Zeiss Meditec AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Carl Zeiss Meditec AG (AFX) total liabilities for a breakdown of total debt and financial obligations.
Carl Zeiss Meditec AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Carl Zeiss Meditec AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alupar Investimento SA
SA:ALUP11
|
0.039x |
|
Kaiser Aluminum Corporation
NASDAQ:KALU
|
-0.025x |
|
Curaleaf Holdings Inc.
TO:CURA
|
0.055x |
|
TMC the metals company Inc
NASDAQ:TMC
|
0.283x |
|
BW LPG Limited
NYSE:BWLP
|
0.092x |
|
Arena Star Group Ltd
TA:ARNA
|
-0.016x |
|
MeHow Innovative Ltd. A
SHE:301363
|
N/A |
|
Mayora Indah Tbk
JK:MYOR
|
0.058x |
Annual Cash Flow Conversion Efficiency for Carl Zeiss Meditec AG (2014–2025)
The table below shows the annual cash flow conversion efficiency of Carl Zeiss Meditec AG from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Carl Zeiss Meditec AG worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €2.13 Billion ≈ $2.49 Billion |
€209.86 Million ≈ $245.35 Million |
0.099x | -17.99% |
| 2024-09-30 | €2.06 Billion ≈ $2.40 Billion |
€247.32 Million ≈ $289.14 Million |
0.120x | +4.17% |
| 2023-09-30 | €2.17 Billion ≈ $2.54 Billion |
€250.86 Million ≈ $293.28 Million |
0.115x | +24.53% |
| 2022-09-30 | €2.03 Billion ≈ $2.37 Billion |
€188.20 Million ≈ $220.02 Million |
0.093x | -57.12% |
| 2021-09-30 | €1.68 Billion ≈ $1.96 Billion |
€362.66 Million ≈ $423.99 Million |
0.216x | +75.67% |
| 2020-09-30 | €1.45 Billion ≈ $1.70 Billion |
€178.53 Million ≈ $208.72 Million |
0.123x | -20.60% |
| 2019-09-30 | €1.42 Billion ≈ $1.66 Billion |
€219.63 Million ≈ $256.78 Million |
0.155x | +8.85% |
| 2018-09-30 | €1.31 Billion ≈ $1.54 Billion |
€187.21 Million ≈ $218.86 Million |
0.142x | +368.64% |
| 2017-09-30 | €1.24 Billion ≈ $1.45 Billion |
€37.73 Million ≈ $44.11 Million |
0.030x | -76.86% |
| 2016-09-30 | €851.16 Million ≈ $995.10 Million |
€111.77 Million ≈ $130.67 Million |
0.131x | +84.54% |
| 2015-09-30 | €797.45 Million ≈ $932.30 Million |
€56.74 Million ≈ $66.34 Million |
0.071x | -14.95% |
| 2014-09-30 | €754.23 Million ≈ $881.77 Million |
€63.10 Million ≈ $73.78 Million |
0.084x | -- |
About Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for ret… Read more